Purposes: The three main components of body composition: skeletal muscle, adipose tissue, and bone, have been associated with cancer outcomes individually, but an integrative assessment combining all three has not been carried out. We aimed to establish a body composition scoring system incorporating all three components to stratify prognosis following hepatic resection for colorectal liver metastases (CRLM).
Methods: The subjects of this retrospective study were 164 patients who underwent hepatic resection for CRLM. The skeletal muscle index (SMI), fat area, and bone mineral density (BMD) were quantified using preoperative computed tomography (CT). A main body composition score (0-3) was developed by assigning 1 point for each high-value component. Patients were stratified into three groups according to their score: low (0), medium (1), and high (2-3).
Results: The main body composition score correlated significantly with disease-free survival and overall survival (OS). The 5-year OS rate was 27.1% in the low-score group, 62.1% in the medium-score group, and 70.6% in the high-score group (p < 0.01). In the multivariable analysis, a low main body composition score predicted poor OS independently (hazard ratio, 3.18; 95% confidence interval, 1.68-6.03; p < 0.01).
Conclusion: The main body composition score, incorporating the SMI, fat area, and BMD, effectively stratified the survival outcomes of patients undergoing hepatic resection for CRLM.
{"title":"The preoperative main body composition scoring system as a strong predictor of colorectal liver metastases.","authors":"Kenei Furukawa, Teppei Kamada, Koichiro Haruki, Yoshihiro Shirai, Masashi Tsunematsu, Shinji Onda, Michinori Matsumoto, Tomohiko Taniai, Mitsuru Yanagaki, Toru Ikegami","doi":"10.1007/s00595-025-03145-4","DOIUrl":"10.1007/s00595-025-03145-4","url":null,"abstract":"<p><strong>Purposes: </strong>The three main components of body composition: skeletal muscle, adipose tissue, and bone, have been associated with cancer outcomes individually, but an integrative assessment combining all three has not been carried out. We aimed to establish a body composition scoring system incorporating all three components to stratify prognosis following hepatic resection for colorectal liver metastases (CRLM).</p><p><strong>Methods: </strong>The subjects of this retrospective study were 164 patients who underwent hepatic resection for CRLM. The skeletal muscle index (SMI), fat area, and bone mineral density (BMD) were quantified using preoperative computed tomography (CT). A main body composition score (0-3) was developed by assigning 1 point for each high-value component. Patients were stratified into three groups according to their score: low (0), medium (1), and high (2-3).</p><p><strong>Results: </strong>The main body composition score correlated significantly with disease-free survival and overall survival (OS). The 5-year OS rate was 27.1% in the low-score group, 62.1% in the medium-score group, and 70.6% in the high-score group (p < 0.01). In the multivariable analysis, a low main body composition score predicted poor OS independently (hazard ratio, 3.18; 95% confidence interval, 1.68-6.03; p < 0.01).</p><p><strong>Conclusion: </strong>The main body composition score, incorporating the SMI, fat area, and BMD, effectively stratified the survival outcomes of patients undergoing hepatic resection for CRLM.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"488-495"},"PeriodicalIF":1.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145426979","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: To investigate the risk factors for incisional hernia (IH) in colorectal cancer patients treated with laparoscopic surgery and midline laparotomy.
Methods: We retrospectively reviewed 140 patients with colorectal cancer and examined their risk factors for IH. We analyzed the clinical findings and associations between these factors and the incidence of IH using Cox proportional hazards models. In particular, we considered umbilical fat.
Results: The cumulative incidence of IH was 33.6% (47 patients), with three symptomatic patients (2.1%). In a multivariate proportional hazard analysis, umbilical fat (p < 0.01; hazard ratio, 6.56; 95% confidence interval, 2.73-15.70) and intermittent suturing with polyglycolic acid (p < 0.01; hazard ratio, 3.56; 95% confidence interval, 1.43-8.87) were significant risk factors for IH. Additionally, long operative times and adjuvant chemotherapy were associated with a high risk of IH in patients with running sutures for abdominal midline incisions.
Conclusion: Umbilical fat may be a significant risk factor for IH after laparoscopic colorectal surgery. Preoperative computed tomography is useful for assessing umbilical fat and identifying high-risk patients. Short-pitch running sutures performed for abdominal closure using a slowly absorbable monofilament suture material within a controlled operative time are essential for preventing IH.
{"title":"Umbilical fat is useful for evaluating the risk of incisional hernia after laparoscopic colorectal surgery.","authors":"Chika Katayama, Yasuaki Enokida, Takuya Shiraishi, Yuta Shibasaki, Takuhisa Okada, Katsuya Osone, Akihiko Sano, Makoto Sakai, Hiroomi Ogawa, Ken Shirabe, Hiroshi Saeki","doi":"10.1007/s00595-025-03150-7","DOIUrl":"10.1007/s00595-025-03150-7","url":null,"abstract":"<p><strong>Purpose: </strong>To investigate the risk factors for incisional hernia (IH) in colorectal cancer patients treated with laparoscopic surgery and midline laparotomy.</p><p><strong>Methods: </strong>We retrospectively reviewed 140 patients with colorectal cancer and examined their risk factors for IH. We analyzed the clinical findings and associations between these factors and the incidence of IH using Cox proportional hazards models. In particular, we considered umbilical fat.</p><p><strong>Results: </strong>The cumulative incidence of IH was 33.6% (47 patients), with three symptomatic patients (2.1%). In a multivariate proportional hazard analysis, umbilical fat (p < 0.01; hazard ratio, 6.56; 95% confidence interval, 2.73-15.70) and intermittent suturing with polyglycolic acid (p < 0.01; hazard ratio, 3.56; 95% confidence interval, 1.43-8.87) were significant risk factors for IH. Additionally, long operative times and adjuvant chemotherapy were associated with a high risk of IH in patients with running sutures for abdominal midline incisions.</p><p><strong>Conclusion: </strong>Umbilical fat may be a significant risk factor for IH after laparoscopic colorectal surgery. Preoperative computed tomography is useful for assessing umbilical fat and identifying high-risk patients. Short-pitch running sutures performed for abdominal closure using a slowly absorbable monofilament suture material within a controlled operative time are essential for preventing IH.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"496-506"},"PeriodicalIF":1.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145438999","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: Urachal remnants are common in neonates and can persist into adulthood. However, their epidemiology in adults remains poorly characterized. We aimed to investigate the prevalence and clinical features of urachal remnants in adult Japanese patients with omphalitis using a nationwide claims database.
Methods: We analyzed data from the Japan Medical Data Center Claims Database (2005-2023) to identify patients ≥ 15 years of age who were diagnosed with omphalitis. The prevalence of urachal remnants, associated diagnoses, surgical interventions, and time to surgery was examined, focusing on sex differences and age distribution.
Results: Of the 11,477 patients with omphalitis, 1836 (16.0%) had urachal remnants, with a male-to-female ratio of 2.53:1. The prevalence peaked in males of 20-34 years of age, exceeding 30%. Surgical intervention was performed in 39.7% of the cases, with a median time to surgery of 2 months. The number of laparoscopic procedures increased after 2014 and surpassed that of open surgeries by 2018. One case of urachal cancer (0.054%) was also identified.
Conclusion: Urachal remnants are relatively common in adults with omphalitis, particularly in young males, and usually require surgery. Given the high prevalence and risk of recurrence, early imaging should be considered in adult omphalitis cases to support a timely diagnosis and intervention.
{"title":"Epidemiology and treatment patterns of urachal remnants in adult patients with omphalitis: a nationwide claims-based study in Japan.","authors":"Ryota Tokunaga, Takenori Yamauchi, Hiroki Den, Shunsuke Omotaka, Suguru Ogihara, Masayuki Isozaki, Takahiro Hobo, Noboru Yokoyama, Haruhiro Inoue, Akatsuki Kokaze","doi":"10.1007/s00595-025-03151-6","DOIUrl":"10.1007/s00595-025-03151-6","url":null,"abstract":"<p><strong>Purpose: </strong>Urachal remnants are common in neonates and can persist into adulthood. However, their epidemiology in adults remains poorly characterized. We aimed to investigate the prevalence and clinical features of urachal remnants in adult Japanese patients with omphalitis using a nationwide claims database.</p><p><strong>Methods: </strong>We analyzed data from the Japan Medical Data Center Claims Database (2005-2023) to identify patients ≥ 15 years of age who were diagnosed with omphalitis. The prevalence of urachal remnants, associated diagnoses, surgical interventions, and time to surgery was examined, focusing on sex differences and age distribution.</p><p><strong>Results: </strong>Of the 11,477 patients with omphalitis, 1836 (16.0%) had urachal remnants, with a male-to-female ratio of 2.53:1. The prevalence peaked in males of 20-34 years of age, exceeding 30%. Surgical intervention was performed in 39.7% of the cases, with a median time to surgery of 2 months. The number of laparoscopic procedures increased after 2014 and surpassed that of open surgeries by 2018. One case of urachal cancer (0.054%) was also identified.</p><p><strong>Conclusion: </strong>Urachal remnants are relatively common in adults with omphalitis, particularly in young males, and usually require surgery. Given the high prevalence and risk of recurrence, early imaging should be considered in adult omphalitis cases to support a timely diagnosis and intervention.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"436-444"},"PeriodicalIF":1.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145293776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-04-01Epub Date: 2025-10-17DOI: 10.1007/s00595-025-03159-y
Go Kamimura, Masaya Aoki, Satomi Imamura, Shoichiro Morizono, Yuto Nonaka, Takuya Tokunaga, Aya Harada-Takeda, Koki Maeda, Toshiyuki Nagata, Kazuhiro Ueda
Purpose: Pleural lavage cytology (PLC) is a recognized prognostic marker in non-small cell lung cancer (NSCLC); however, the impact of serial intraoperative changes remains unclear.
Methods: We retrospectively analyzed 439 patients who underwent curative NSCLC resection. PLC was performed at three intraoperative points: after thoracotomy (pre-PLC), after lung resection, and after lavage at chest closure (post-PLC). Associations between recurrence-free survival (RFS) and pleural dissemination were evaluated by a Kaplan-Meier analysis and Fine and Gray competing risks regression.
Results: Forty-one patients had at least one positive PLC result. RFS was the lowest in pre-PLC( +)/post-PLC( +) (n = 10), intermediate in pre-PLC(-)/post-PLC( +) (n = 11), and best in post-PLC( -) (n = 20). Importantly, post-PLC( -) patients included 13 patients with pre-PLC positivity, yet their RFS matched that of consistently negative cases (n = 398). The cumulative incidence of pleural dissemination exhibited a similar pattern. In a multivariate analysis, post-PLC positivity, but not pre-PLC positivity, independently predicted poor RFS (hazard ratio, 3.06; p < 0.001).
Conclusion: Post-PLC, but not pre-PLC, provides decisive prognostic information for recurrence and pleural dissemination, likely reflecting residual lavage-resistant tumor clusters. Importantly, combining pre- and post-PLC results refines risk stratification and identifies the poorest-outcome subgroup that may benefit from adjuvant therapy.
{"title":"Serial changes in pleural lavage cytology during lung cancer surgery predict recurrence and pleural dissemination.","authors":"Go Kamimura, Masaya Aoki, Satomi Imamura, Shoichiro Morizono, Yuto Nonaka, Takuya Tokunaga, Aya Harada-Takeda, Koki Maeda, Toshiyuki Nagata, Kazuhiro Ueda","doi":"10.1007/s00595-025-03159-y","DOIUrl":"10.1007/s00595-025-03159-y","url":null,"abstract":"<p><strong>Purpose: </strong>Pleural lavage cytology (PLC) is a recognized prognostic marker in non-small cell lung cancer (NSCLC); however, the impact of serial intraoperative changes remains unclear.</p><p><strong>Methods: </strong>We retrospectively analyzed 439 patients who underwent curative NSCLC resection. PLC was performed at three intraoperative points: after thoracotomy (pre-PLC), after lung resection, and after lavage at chest closure (post-PLC). Associations between recurrence-free survival (RFS) and pleural dissemination were evaluated by a Kaplan-Meier analysis and Fine and Gray competing risks regression.</p><p><strong>Results: </strong>Forty-one patients had at least one positive PLC result. RFS was the lowest in pre-PLC( +)/post-PLC( +) (n = 10), intermediate in pre-PLC(-)/post-PLC( +) (n = 11), and best in post-PLC( -) (n = 20). Importantly, post-PLC( -) patients included 13 patients with pre-PLC positivity, yet their RFS matched that of consistently negative cases (n = 398). The cumulative incidence of pleural dissemination exhibited a similar pattern. In a multivariate analysis, post-PLC positivity, but not pre-PLC positivity, independently predicted poor RFS (hazard ratio, 3.06; p < 0.001).</p><p><strong>Conclusion: </strong>Post-PLC, but not pre-PLC, provides decisive prognostic information for recurrence and pleural dissemination, likely reflecting residual lavage-resistant tumor clusters. Importantly, combining pre- and post-PLC results refines risk stratification and identifies the poorest-outcome subgroup that may benefit from adjuvant therapy.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"455-461"},"PeriodicalIF":1.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145309183","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-04-01Epub Date: 2025-12-13DOI: 10.1007/s00595-025-03177-w
XiaoJuan Chen, SiYu Yan
Stem cell transplantation has emerged as a promising therapeutic modality for the treatment of anal fistulas, showing significant potential in addressing this challenging condition. This review aims to summarize the latest research advancements in the field of stem cell therapy for anal fistula, focusing on the underlying mechanisms that contribute to healing, the clinical applications that have been explored in various studies, and the assessment of therapeutic efficacy. Despite these encouraging results, several issues remain, including the optimal source of stem cells, methods of administration, and long-term outcomes. The review will also discuss future research directions, emphasizing the need for standardized protocols and larger-scale clinical trials to establish the safety and effectiveness of stem cell transplantation in routine clinical practice.
{"title":"Research progress of stem cell transplantation in the treatment of anal fistula.","authors":"XiaoJuan Chen, SiYu Yan","doi":"10.1007/s00595-025-03177-w","DOIUrl":"10.1007/s00595-025-03177-w","url":null,"abstract":"<p><p>Stem cell transplantation has emerged as a promising therapeutic modality for the treatment of anal fistulas, showing significant potential in addressing this challenging condition. This review aims to summarize the latest research advancements in the field of stem cell therapy for anal fistula, focusing on the underlying mechanisms that contribute to healing, the clinical applications that have been explored in various studies, and the assessment of therapeutic efficacy. Despite these encouraging results, several issues remain, including the optimal source of stem cells, methods of administration, and long-term outcomes. The review will also discuss future research directions, emphasizing the need for standardized protocols and larger-scale clinical trials to establish the safety and effectiveness of stem cell transplantation in routine clinical practice.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"411-420"},"PeriodicalIF":1.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145752234","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: To compare survival outcomes between patients undergoing upfront surgery and those receiving neoadjuvant therapy followed by surgery for pancreatic cancer stratified by pathological stage.
Methods: We retrospectively analyzed data from 456 patients who underwent curative-intent pancreatectomy between 2011 and 2023. The study patients were categorized into upfront surgery (n = 290) and neoadjuvant therapy (n = 166) groups. The overall and disease-free survival rates were compared between the groups within each pathological stage. Univariate and multivariate analyses were performed for patients with Stage I disease.
Results: In Stage IA, overall and disease-free survival were significantly better in the upfront surgery group than in the neoadjuvant therapy group (P = 0.0022 and P = 0.0012, respectively). There were no significant differences between the groups in patients with Stage II disease. A multivariate analysis of patients with Stage I disease identified neoadjuvant therapy (HR: 4.053, P = 0.0010), biliary drainage (HR: 2.342, P = 0.0399), and absence of adjuvant chemotherapy (HR: 4.563, P = 0.0004) as independent predictors of poor overall survival.
Conclusion: Even within the same pathological stage, the survival outcomes differed between the upfront surgery and neoadjuvant therapy groups. These findings suggest that treatment history should be considered when interpreting the pathological stage and assessing the prognosis of patients with pancreatic cancer.
目的:比较按病理分期进行胰腺癌术前和术后新辅助治疗患者的生存结局。方法:我们回顾性分析了2011年至2023年间456例接受治疗性胰腺切除术的患者的数据。研究患者分为前期手术组(290例)和新辅助治疗组(166例)。比较各组在各病理阶段的总生存率和无病生存率。对I期疾病患者进行单因素和多因素分析。结果:在IA期,前期手术组的总生存率和无病生存率明显优于新辅助治疗组(P = 0.0022和P = 0.0012)。在II期疾病患者中,两组间无显著差异。一项对I期疾病患者的多变量分析发现,新辅助治疗(HR: 4.053, P = 0.0010)、胆道引流(HR: 2.342, P = 0.0399)和缺乏辅助化疗(HR: 4.563, P = 0.0004)是总生存差的独立预测因素。结论:即使在同一病理阶段,术前治疗组和新辅助治疗组的生存结局也存在差异。这些结果提示,在解释胰腺癌患者的病理分期和评估预后时应考虑治疗史。
{"title":"Prognostic discrepancies between surgery-first and neoadjuvant-treated resected pancreatic cancer in the same pathological stage.","authors":"Suguru Yamada, Kenji Oshima, Kosuke Nomoto, Shotaro Sanada, Yukiko Oshima, Masafumi Ito, Akimasa Nakao","doi":"10.1007/s00595-025-03163-2","DOIUrl":"10.1007/s00595-025-03163-2","url":null,"abstract":"<p><strong>Purpose: </strong>To compare survival outcomes between patients undergoing upfront surgery and those receiving neoadjuvant therapy followed by surgery for pancreatic cancer stratified by pathological stage.</p><p><strong>Methods: </strong>We retrospectively analyzed data from 456 patients who underwent curative-intent pancreatectomy between 2011 and 2023. The study patients were categorized into upfront surgery (n = 290) and neoadjuvant therapy (n = 166) groups. The overall and disease-free survival rates were compared between the groups within each pathological stage. Univariate and multivariate analyses were performed for patients with Stage I disease.</p><p><strong>Results: </strong>In Stage IA, overall and disease-free survival were significantly better in the upfront surgery group than in the neoadjuvant therapy group (P = 0.0022 and P = 0.0012, respectively). There were no significant differences between the groups in patients with Stage II disease. A multivariate analysis of patients with Stage I disease identified neoadjuvant therapy (HR: 4.053, P = 0.0010), biliary drainage (HR: 2.342, P = 0.0399), and absence of adjuvant chemotherapy (HR: 4.563, P = 0.0004) as independent predictors of poor overall survival.</p><p><strong>Conclusion: </strong>Even within the same pathological stage, the survival outcomes differed between the upfront surgery and neoadjuvant therapy groups. These findings suggest that treatment history should be considered when interpreting the pathological stage and assessing the prognosis of patients with pancreatic cancer.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"515-524"},"PeriodicalIF":1.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145453251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purpose: This study aimed to evaluate the feasibility and outcomes of curative-intent surgery in patients with clinically node-positive non-small cell lung cancer (NCSLC) and interstitial lung disease (ILD).
Methods: We retrospectively evaluated patients with clinically node-positive NSCLC and ILD, who underwent curative-intent surgery between 2012 and 2022. Survival outcomes and complications were also assessed. Risk stratification for acute exacerbations of ILD (AE-ILD) was performed using the Japanese Association for Chest Surgery (JACS) score.
Results: Twenty-eight patients were included in the study. Postoperative AE-ILD developed in 17.9% of patients within 30 days and 25.0% within 90 days. The incidence was lower in the low-risk group than in the intermediate-risk group (30 days: 12.5 vs. 20.0%; 90 days: 12.5 vs. 30.0%). No ILD-related deaths occurred within one year postoperatively in the low-risk group, whereas 71.4% of the deaths in the intermediate-risk group were ILD-related. The median overall survival (OS) and recurrence-free survival (RFS) were 19.5 and 13.7 months, respectively. Patients with cN1 or cN2a had favorable outcomes (OS: 28.5 and 28.6 months; RFS: 13.7 and 28.6 months, respectively), whereas those with cN2b showed poor survival (OS/RFS: 2.4 months).
Conclusions: Curative-intent surgery may offer survival benefits for selected patients, particularly those with limited nodal disease and a low risk of AE-ILD.
目的:本研究旨在评估临床淋巴结阳性非小细胞肺癌(NCSLC)和间质性肺疾病(ILD)患者治疗目的手术的可行性和结果。方法:我们回顾性评估了临床淋巴结阳性的非小细胞肺癌和ILD患者,这些患者在2012年至2022年间接受了治疗目的手术。生存结果和并发症也进行了评估。使用日本胸外科协会(JACS)评分对ILD急性加重(AE-ILD)进行风险分层。结果:28例患者纳入研究。17.9%的患者术后30天内发生AE-ILD, 25.0%的患者术后90天内发生AE-ILD。低危组的发生率低于中危组(30天:12.5 vs. 20.0%; 90天:12.5 vs. 30.0%)。低危组术后一年内无ild相关死亡,而中危组71.4%的死亡与ild相关。中位总生存期(OS)和无复发生存期(RFS)分别为19.5和13.7个月。cN1或cN2a患者预后良好(生存期分别为28.5和28.6个月;RFS分别为13.7和28.6个月),而cN2b患者生存期较差(OS/RFS为2.4个月)。结论:以治愈为目的的手术可能为特定患者提供生存益处,特别是那些有限淋巴结疾病和AE-ILD低风险的患者。
{"title":"Feasibility and outcomes of curative-intent surgery for clinically node-positive non-small cell lung cancer with interstitial lung disease.","authors":"Masatoshi Kanayama, Manabu Yasuda, Toshihiro Osaki, Hina Jojiki, Natsumasa Nishizawa, Yasuhiro Chikaishi, Fumihiro Tanaka","doi":"10.1007/s00595-025-03154-3","DOIUrl":"10.1007/s00595-025-03154-3","url":null,"abstract":"<p><strong>Purpose: </strong>This study aimed to evaluate the feasibility and outcomes of curative-intent surgery in patients with clinically node-positive non-small cell lung cancer (NCSLC) and interstitial lung disease (ILD).</p><p><strong>Methods: </strong>We retrospectively evaluated patients with clinically node-positive NSCLC and ILD, who underwent curative-intent surgery between 2012 and 2022. Survival outcomes and complications were also assessed. Risk stratification for acute exacerbations of ILD (AE-ILD) was performed using the Japanese Association for Chest Surgery (JACS) score.</p><p><strong>Results: </strong>Twenty-eight patients were included in the study. Postoperative AE-ILD developed in 17.9% of patients within 30 days and 25.0% within 90 days. The incidence was lower in the low-risk group than in the intermediate-risk group (30 days: 12.5 vs. 20.0%; 90 days: 12.5 vs. 30.0%). No ILD-related deaths occurred within one year postoperatively in the low-risk group, whereas 71.4% of the deaths in the intermediate-risk group were ILD-related. The median overall survival (OS) and recurrence-free survival (RFS) were 19.5 and 13.7 months, respectively. Patients with cN1 or cN2a had favorable outcomes (OS: 28.5 and 28.6 months; RFS: 13.7 and 28.6 months, respectively), whereas those with cN2b showed poor survival (OS/RFS: 2.4 months).</p><p><strong>Conclusions: </strong>Curative-intent surgery may offer survival benefits for selected patients, particularly those with limited nodal disease and a low risk of AE-ILD.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"445-454"},"PeriodicalIF":1.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145303452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Purposes: Postoperative delirium (POD) is a serious complication in elderly patients undergoing gastrointestinal (GI) cancer surgery. This study aimed to identify the perioperative risk factors for POD, focusing on domain-specific cognitive function.
Methods: We retrospectively analyzed patients ≥ 65 years old who underwent GI cancer surgery and preoperative geriatric screening. POD was assessed using the Delirium Symptomatology Test. Cognitive domains were evaluated using the Japanese Montreal Cognitive Assessment (MoCA-J). A receiver operating characteristic (ROC) analysis identified the most predictive domain combination and compared its discriminative performance with that of conventional tools. Independent associations with POD were examined using Firth's logistic regression.
Results: Of 167 patients, 13 (7.8%) developed POD. The MoCA-J Memory + Orientation composite score showed the highest predictive accuracy. In the multivariable analysis, a composite score < 7 (odds ratio [OR] = 12.81, 95% confidence interval [CI]: 1.95-84.0), older age (per year, OR = 1.10, 95% CI: 1.01-1.21), preexisting respiratory disease (OR = 7.82, 95% CI: 1.40-43.9), and intraoperative blood loss (per 100 ml increment, OR = 1.53, 95% CI: 1.05-2.25) were independently associated with POD.
Conclusions: The MoCA-J domain-specific composite score for memory and orientation was the strongest predictor of POD, alongside established factors, such as older age, preexisting respiratory disease, and intraoperative blood loss.
{"title":"Montreal cognitive assessment domain-specific and clinical predictors of postoperative delirium in elderly gastrointestinal cancer patients.","authors":"Haruna Yamaguchi, Ryohei Kawabata, Shiori Yoshiyama, Mamiko Fujiwara, Norihisa Matsukawa, Masaru Kitamura, Tomohira Takeoka, Hisashi Hara, Terukazu Yoshihara, Akihiro Kitagawa, Hideo Tomihara, Atsushi Naito, Masahiro Murakami, Kazuhiro Shimomura, Shingo Noura, Atsushi Miyamoto","doi":"10.1007/s00595-025-03171-2","DOIUrl":"10.1007/s00595-025-03171-2","url":null,"abstract":"<p><strong>Purposes: </strong>Postoperative delirium (POD) is a serious complication in elderly patients undergoing gastrointestinal (GI) cancer surgery. This study aimed to identify the perioperative risk factors for POD, focusing on domain-specific cognitive function.</p><p><strong>Methods: </strong>We retrospectively analyzed patients ≥ 65 years old who underwent GI cancer surgery and preoperative geriatric screening. POD was assessed using the Delirium Symptomatology Test. Cognitive domains were evaluated using the Japanese Montreal Cognitive Assessment (MoCA-J). A receiver operating characteristic (ROC) analysis identified the most predictive domain combination and compared its discriminative performance with that of conventional tools. Independent associations with POD were examined using Firth's logistic regression.</p><p><strong>Results: </strong>Of 167 patients, 13 (7.8%) developed POD. The MoCA-J Memory + Orientation composite score showed the highest predictive accuracy. In the multivariable analysis, a composite score < 7 (odds ratio [OR] = 12.81, 95% confidence interval [CI]: 1.95-84.0), older age (per year, OR = 1.10, 95% CI: 1.01-1.21), preexisting respiratory disease (OR = 7.82, 95% CI: 1.40-43.9), and intraoperative blood loss (per 100 ml increment, OR = 1.53, 95% CI: 1.05-2.25) were independently associated with POD.</p><p><strong>Conclusions: </strong>The MoCA-J domain-specific composite score for memory and orientation was the strongest predictor of POD, alongside established factors, such as older age, preexisting respiratory disease, and intraoperative blood loss.</p>","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":"507-514"},"PeriodicalIF":1.6,"publicationDate":"2026-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145445920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Risk factors for seroma formation after ALT flap harvest: a retrospective study focused on age and the fascia harvest area.","authors":"Kenji Tsuboi, Kento Yamamoto, Eisei Yoshizawa, Masashi Hayakawa, Hiroshi Furukawa","doi":"10.1007/s00595-026-03272-6","DOIUrl":"https://doi.org/10.1007/s00595-026-03272-6","url":null,"abstract":"","PeriodicalId":22163,"journal":{"name":"Surgery Today","volume":" ","pages":""},"PeriodicalIF":1.6,"publicationDate":"2026-03-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147487496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}